| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXHL2100170 | 盐酸罗哌卡因脂质体混悬注射液 | ropivacaine hydrochloride | Injection | Chemical Drugs(2.2) | New Drug Application | 2021-03-05 | 南京绿叶制药有限公司 | Nanjing Sike Medicine Industry Co Ltd | In Review | 2021-03-05 | view |